Cargando…
Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice
We have recently developed probiotics that can express bovine, human, or porcine lactoferrin (LF), and the present study evaluated the effect of these probiotics in improving non-alcoholic fatty liver disease (NAFLD). Three kinds of probiotic supplements, including lactic acid bacteria (LAB), LAB/LF...
Autores principales: | Liu, Zhen-Shu, Li, Pei-Lin, Ku, Yu-We, Chen, Po-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694622/ https://www.ncbi.nlm.nih.gov/pubmed/36363807 http://dx.doi.org/10.3390/microorganisms10112215 |
Ejemplares similares
-
A Single Plasmid of Nisin-Controlled Bovine and Human Lactoferrin Expressing Elevated Antibacterial Activity of Lactoferrin-Resistant Probiotic Strains
por: Liu, Zhen-Shu, et al.
Publicado: (2021) -
Effects of Metformin Combined with Lactoferrin on Lipid Accumulation and Metabolism in Mice Fed with High-Fat Diet
por: Min, Qing-Qing, et al.
Publicado: (2018) -
Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver
por: Mei, Lu, et al.
Publicado: (2015) -
Myopia Is Suppressed by Digested Lactoferrin or Holo-Lactoferrin Administration
por: Liang, Yifan, et al.
Publicado: (2023) -
CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice
por: Tan, Rongrong, et al.
Publicado: (2022)